NUE
54
-4
USB
68
2
VIX
19
-6
MU
79
4
CMI
75
4
PFE
45
12
STX
64
-5
DHI
37
-3
ORCL
37
4
TXN
52
2
IRM
44
3
TRIP
52
3
UA
36
3
SYK
35
4
SCHW
67
3
PX
53
3
PGR
44
2
AXP
74
4
PH
64
2
ADI
73
2
NUE
54
-4
USB
68
2
VIX
19
-6
MU
79
4
CMI
75
4
PFE
45
12
STX
64
-5
DHI
37
-3
ORCL
37
4
TXN
52
2
IRM
44
3
TRIP
52
3
UA
36
3
SYK
35
4
SCHW
67
3
PX
53
3
PGR
44
2
AXP
74
4
PH
64
2
ADI
73
2
Financhill
Back

Vanguard Short-Term Tax-Exempt Bond ETF Vs. Oruka Therapeutics, Inc. Industry Stock Comparison

Sell
48

VTES
Vanguard Short-Term Tax-Exempt Bond ETF

Last Price:
$101.58
Seasonality Move:
1.31%
Sell
40

ORKA
Oruka Therapeutics, Inc.

Last Price:
$32.34
Seasonality Move:
-10.99%
Sell
48
Vanguard Short-Term Tax-Exempt Bond ETF (VTES) is a Sell

Is Vanguard Short-Term Tax-Exempt Bond ETF a Buy, Sell or Hold?

  • The current Vanguard Short-Term Tax-Exempt Bond ETF [VTES] share price is $101.60. The Score for VTES is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • VTES is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Oruka Therapeutics, Inc. (ORKA) is a Sell

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $31.97. The Score for ORKA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ORKA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VTES Stock Price Chart

What is Vanguard Short-Term Tax-Exempt Bond ETF's stock price today?

  • The Vanguard Short-Term Tax-Exempt Bond ETF share price today is $101.60
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VTES is experiencing slight selling pressure.

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $31.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing slight buying pressure.

VTES Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 22.59 Buy
Relative Strength Index (14 RSI): 56.35 Buy
Chaikin Money Flow: -18379 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (101.43 - 101.59) Buy
Bollinger Bands (100): (101.43 - 101.89) Sell

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.74 Buy
Relative Strength Index (14 RSI): 61.53 Buy
Chaikin Money Flow: 394649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.23 - 31.09) Buy
Bollinger Bands (100): (15.89 - 28.91) Buy

VTES Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 101.55 Buy
20-day SMA: 101.52 Buy
50-day SMA: 101.55 Buy
200-day SMA: 101.04 Buy
8-day EMA: 64.41 Buy
20-day EMA: 33.51 Buy
50-day EMA: 15.02 Buy
200-day EMA: 3.98 Buy

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.97 Buy
20-day SMA: 30.06 Buy
50-day SMA: 28.52 Buy
200-day SMA: 16.89 Buy
8-day EMA: 30.34 Buy
20-day EMA: 29.78 Buy
50-day EMA: 27.54 Buy
200-day EMA: 21.05 Buy

Vanguard Short-Term Tax-Exempt Bond ETF Earnings Growth & VTES Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and a decrease next year of $0.32 per share.

Vanguard Short-Term Tax-Exempt Bond ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):